The portfolio maintains a sizable cost advantage over competitors, priced within the lowest fee quintile among peers.
Health Care Select Sector SPDR® ETF XLV
Morningstar’s Analysis XLV
Will XLV outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 55.3
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Eli Lilly and Co | 11.67 | 4.4 Bil | Healthcare |
UnitedHealth Group Inc | 8.64 | 3.2 Bil | Healthcare |
Johnson & Johnson | 6.80 | 2.6 Bil | Healthcare |
Merck & Co Inc | 6.20 | 2.3 Bil | Healthcare |
AbbVie Inc | 5.66 | 2.1 Bil | Healthcare |
Thermo Fisher Scientific Inc | 4.12 | 1.5 Bil | Healthcare |
Abbott Laboratories | 3.59 | 1.3 Bil | Healthcare |
Danaher Corp | 3.07 | 1.2 Bil | Healthcare |
Pfizer Inc | 2.80 | 1.1 Bil | Healthcare |
Amgen Inc | 2.76 | 1.0 Bil | Healthcare |